A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae

Table 4 DBA and BFBA in six-time points (\(\overline{x}\) ± SD)

		MLPN group (n = 15)	Control group (n = 15)	t	P
T0	DBA, mm	5.57 ± 0.75	5.61 ± 0.32	0.160	0.874
T0	BFBA, ml/min	439.13 ± 56.57	413.93 ± 51.32	1.278	0.212
T1	DBA, mm	6.30 ± 0.29^***	5.77 ± 0.36^***	4.391	0.000
T1	BFBA, ml/min	678.67 ± 45.31^***	629.20 ± 54.99^***	2.689	0.012
T2	DBA, mm	6.83 ± 0.43^***	6.62 ± 0.57^***	1.192	0.243
T2	BFBA, ml/min	805.13 ± 75.33^***	764.20 ± 47.43^***	1.781	0.086
T3	DBA, mm	6.97 ± 0.27^***	6.82 ± 0.53^***	0.967	0.342
T3	BFBA, ml/min	904.87 ± 48.15^***	870.27 ± 65.42^***	1.650	0.110
T4	DBA, mm	7.36 ± 0.31^***	7.15 ± 0.40^***	1.600	0.121
T4	BFBA, ml/min	1048.70 ± 61.62^***	942.24 ± 63.79^***	4.651	0.000
T5	DBA, mm	7.93 ± 0.34^***	7.76 ± 0.45^***	1.162	0.255
T5	BFBA, ml/min	972.84 ± 91.38^***	971.89 ± 63.73^***	0.033	0.974

^***Significant changes compared to T0 (P < 0.001)
MLPN: moxibustion at Laogong interval with Panax notoginseng; DBA: diameter of arteria brachialis; BFBA: blood flow of arteria brachialis

ISSN: 1749-8546